Skip to main content
. 2018 Aug 24;9(66):32624–32641. doi: 10.18632/oncotarget.25976

Table 4. Concentration of MMP-9 detected by ELISA with commercial kit and RPPA assay with corresponding antibody.

MMP-9 ELISA (ng/ml) RPPA assay (ng/ml)
MAB9111 AF911 MAB936
Serum 1 281.81 26.61 509.36 1553.63
Serum 2 187.34 15.09 1463.71 169.69
Serum 3 160.20 17.95 934.36 1098.21
Serum 4 194.23 20.75 1090.33 891.64
Serum 5 137.08 15.21 3895.77 1173.73
Serum 6 201.16 20.00 0.00 0.00
Serum 7 209.80 22.40 1697.66 746.62
Serum 8 334.56 37.30 496.50 1576.51
Serum 9 341.58 35.69 727.54 1522.98
Serum 10 272.33 19.94 535.20 664.56
Serum 11 260.90 27.15 1220.34 404.88
Serum 12 227.17 26.94 1097.50 897.86
Serum 13 372.61 36.90 256.46 1229.85
Serum 14 336.74 37.98 502.92 1266.10
Serum 15 145.81 18.27 2970.56 609.03
Serum 16 183.26 19.40 2643.36 480.14
Serum 17 205.81 19.92 1546.16 864.02
Serum 18 127.42 13.23 5154.74 374.48